AbstractAdeno-associated virus (AAV) serotypes 1 to 5 are currently under development as clinical gene delivery vectors for the treatment of human diseases. However, the ubiquitous nature of their cell surface receptors, heparin sulfate (AAV2 and 3) and sialic acids (AAV4 and 5), can preclude specific tissue targeting in vivo. Structural studies of AAV4 were initiated to characterize its capsid surface for re-targeting manipulations. Crystals obtained diffracted synchrotron radiation to 3.2 Å resolution. The unit cell is body-centered orthorhombic, I222, with a = 339.6, b = 319.2 and c = 285.0 Å. The virus particle orientation and position have been determined
AbstractCrystal structures of the AAV-6 capsid at 3Å reveal a subunit fold homologous to other parvo...
Adeno-associated virus serotype 9 (AAV9) has enhanced capsid-associated tropism for cardiac muscle a...
A new adeno-associated virus (AAV), referred to as AAV(VR-942), has been isolated as a contaminant o...
AbstractAdeno-associated virus (AAV) serotypes 1 to 5 are currently under development as clinical ge...
AbstractAdeno-associated viruses (AAVs) are leading candidate vectors for human gene therapy. AAV se...
AbstractAdeno-associated virus serotype 2 (AAV-2) is a leading candidate vector for gene therapy. Ce...
The three-dimensional structure of adeno-associated virus (AAV) serotype 6 (AAV6) was determined usi...
Adeno-associated viruses (AAVs) are vehicles for gene therapy in humans, but currently only a limite...
ABSTRACT The adeno-associated viruses (AAVs), which are being developed as gene delivery vectors, di...
Adeno-associated viruses (AAVs) are small single-stranded DNA viruses that can package and deliver n...
ABSTRACT: Adeno-associated virus (AAV) is a key candidate in the development of gene therapy. In thi...
Adeno-associated virus (AAV) vectors are preeminent in emerging clinical gene therapies. Generalizin...
Adeno-associated viruses (AAV) are utilized as gene transfer vectors in the treatment of monogenic d...
Adeno-associated virus serotype 9 (AAV9) has enhanced capsid-associated tropism for cardiac muscle a...
UnlabelledThe clinical utility of the adeno-associated virus (AAV) gene delivery system has been val...
AbstractCrystal structures of the AAV-6 capsid at 3Å reveal a subunit fold homologous to other parvo...
Adeno-associated virus serotype 9 (AAV9) has enhanced capsid-associated tropism for cardiac muscle a...
A new adeno-associated virus (AAV), referred to as AAV(VR-942), has been isolated as a contaminant o...
AbstractAdeno-associated virus (AAV) serotypes 1 to 5 are currently under development as clinical ge...
AbstractAdeno-associated viruses (AAVs) are leading candidate vectors for human gene therapy. AAV se...
AbstractAdeno-associated virus serotype 2 (AAV-2) is a leading candidate vector for gene therapy. Ce...
The three-dimensional structure of adeno-associated virus (AAV) serotype 6 (AAV6) was determined usi...
Adeno-associated viruses (AAVs) are vehicles for gene therapy in humans, but currently only a limite...
ABSTRACT The adeno-associated viruses (AAVs), which are being developed as gene delivery vectors, di...
Adeno-associated viruses (AAVs) are small single-stranded DNA viruses that can package and deliver n...
ABSTRACT: Adeno-associated virus (AAV) is a key candidate in the development of gene therapy. In thi...
Adeno-associated virus (AAV) vectors are preeminent in emerging clinical gene therapies. Generalizin...
Adeno-associated viruses (AAV) are utilized as gene transfer vectors in the treatment of monogenic d...
Adeno-associated virus serotype 9 (AAV9) has enhanced capsid-associated tropism for cardiac muscle a...
UnlabelledThe clinical utility of the adeno-associated virus (AAV) gene delivery system has been val...
AbstractCrystal structures of the AAV-6 capsid at 3Å reveal a subunit fold homologous to other parvo...
Adeno-associated virus serotype 9 (AAV9) has enhanced capsid-associated tropism for cardiac muscle a...
A new adeno-associated virus (AAV), referred to as AAV(VR-942), has been isolated as a contaminant o...